Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • Nepal protests
  • Nepal Protests Live
  • Vice-presidential elections
  • iPhone 17
  • IND vs PAK cricket
  • Israel-Hamas war
fp-logo
Ranbaxy net jumps 4-fold on forex gain, Lipitor sales
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Business
  • Ranbaxy net jumps 4-fold on forex gain, Lipitor sales

Ranbaxy net jumps 4-fold on forex gain, Lipitor sales

FP Archives • December 20, 2014, 08:12:30 IST
Whatsapp Facebook Twitter

Shares of Ranbaxy were trading at Rs 514.20 on the BSE in late afternoon trade, up 4.15 per cent from its previous close.

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
Ranbaxy net jumps 4-fold on forex gain, Lipitor sales

Drug major Ranbaxy Laboratories today said its consolidated net profit surged over four-fold

to Rs 1,246.76 crore during the first quarter ended March 31, 2012,against Rs 304.38 crore during the year-ago period on account of forex gains of around Rs 345 crore.

The company has received an exceptional gain of Rs 345 crore arising out of forex during the quarter. Analysts on average had expected net profit at Rs 408 crore and revenues at Rs 3,720 crore. Moreover,Cholesterol buster drug Lipitor boosted margins in the March quarter.

STORY CONTINUES BELOW THIS AD

Sales in the north American market more than doubled to Rs 2093 crore in the period, the first full quarter of sales of its copycat version of blockbuster Lipitor. Ranbaxy launched the generic in December 2011 in the United States followed by European markets.

More from Business
Hyundai India’s Rs 27,870 crore IPO oversubscribed by 2.28X, largely driven by institutional investors Hyundai India’s Rs 27,870 crore IPO oversubscribed by 2.28X, largely driven by institutional investors How Indian fintech startups are driving Malaysia’s UPI-like digital payments revolution How Indian fintech startups are driving Malaysia’s UPI-like digital payments revolution

Other than the innovator Pfizer, Ranbaxy and Watson Pharmaceuticals are the only two drugmakers allowed to sell generic Lipitor in the United States until May 31.

[caption id=“attachment_303836” align=“alignleft” width=“380” caption=“On a standalone basis, the company posted a net profit of Rs 827.23 crore for the first quarter”] ![](https://images.firstpost.com/wp-content/uploads/2012/05/pills.jpg "pills") [/caption]

Net sales of the company rose to Rs 3,695.40 crore for the quarter ended March 31, 2012, as against Rs 2,141.49 crore during the same period of previous year.

On a standalone basis, the company posted a net profit of Rs 827.23 crore for the first quarter, while it had a net loss of Rs 52.9 crore in the corresponding period of last year. The company’s net sales on standalone basis rose to Rs 1,810.22 crore during the first quarter, as against Rs 1,054.92 crore in the same period of last year.

Impact Shorts

More Shorts
Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

As Trump weaponises tariff, Fed sees a bigger worry: Not jobs, but rising prices in America

As Trump weaponises tariff, Fed sees a bigger worry: Not jobs, but rising prices in America

Commenting on results, Ranbaxy CEO and Managing Director Arun Sawhney said: “The focus on key products and markets, while maintaining emphasis on further strengthening quality and compliance standards, has had a positive impact on the performance of Ranbaxy during the quarter”.

Shares of Ranbaxy were trading at Rs 514.20 on the BSE in late afternoon trade, up 4.15 per cent from its previous close.

STORY CONTINUES BELOW THIS AD

Agencies

Tags
BSE Sensex Ranbaxy Laboratories EarningsShow Ranbaxy Laboratories Ltd
End of Article
Written by FP Archives

see more

Latest News
Find us on YouTube
Subscribe
End of Article

Impact Shorts

Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

Tata Harrier EV vs Mahindra XEV 9e: Design and road presence compared

The Tata Harrier EV and Mahindra XEV 9e are new electric SUVs in India. The Harrier EV has a modern, familiar design, while the XEV 9e features a bold, striking look. They cater to different preferences: the Harrier EV for subtle elegance and the XEV 9e for expressive ruggedness.

More Impact Shorts

Top Stories

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched

Who is CP Radhakrishnan, India's next vice-president?

Who is CP Radhakrishnan, India's next vice-president?

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Israel informed US ahead of strikes on Hamas leaders in Doha, says White House

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV